Head to Head Review: LifeStance Health Group (NASDAQ:LFST) versus New York Health Care (OTCMKTS:BBAL)

LifeStance Health Group (NASDAQ:LFST) and New York Health Care (OTCMKTS:BBAL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Institutional & Insider Ownership

85.5% of LifeStance Health Group shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by company insiders. Comparatively, 6.7% of New York Health Care shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares LifeStance Health Group and New York Health Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
New York Health Care	N/A	N/A	N/A

Volatility & Risk

LifeStance Health Group has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, New York Health Care has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

Earnings & Valuation

This table compares LifeStance Health Group and New York Health Care”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42 billion	2.47	$9.66 million	$0.06	151.08
New York Health Care	N/A	N/A	N/A	N/A	N/A

LifeStance Health Group has higher revenue and earnings than New York Health Care.

Analyst Recommendations

This is a breakdown of current ratings for LifeStance Health Group and New York Health Care, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0	3	6	2	2.91
New York Health Care	0	0	0	0	0.00

LifeStance Health Group presently has a consensus target price of $9.75, indicating a potential upside of 7.56%. Given LifeStance Health Group’s stronger consensus rating and higher probable upside, equities analysts plainly believe LifeStance Health Group is more favorable than New York Health Care.

Summary

LifeStance Health Group beats New York Health Care on 10 of the 11 factors compared between the two stocks.

About LifeStance Health Group

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

About New York Health Care

New York Health Care, Inc. operates as a home care services agency primarily in New York. The company offers various home care services, such as companionship services, homemaker/housekeeper staff, professional and practical nurses, home health aides, care givers, geriatric care, and dementia and alzheimer care services. It also provides insurance services. The company was founded in 1983 and is based in Valley Stream, New York.